pH-Responsive Nanoparticles for Delivery of Paclitaxel to the Injury Site for Inhibiting Vascular Restenosis
A high incidence of restenosis has been reported at the site of inflammation following angioplasty and stent implantation. The anti-proliferative drug paclitaxel (PTX) could help to reduce inflammation and restenosis; however, it has poor water solubility and serious adverse side effects at high dos...
Saved in:
Main Authors: | Huiru Zhu (Author), Li Kong (Author), Xu Zhu (Author), Tingting Ran (Author), Xiaojuan Ji (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanoparticle-based approaches for treating restenosis after vascular injury
by: Liangfeng Zhao, et al.
Published: (2024) -
Effect of pH-sensitive nanoparticles on inhibiting oral biofilms
by: Xinyu Peng, et al.
Published: (2022) -
Co-Delivery of an Innovative Organoselenium Compound and Paclitaxel by pH-Responsive PCL Nanoparticles to Synergistically Overcome Multidrug Resistance in Cancer
by: Daniela Mathes, et al.
Published: (2024) -
Legumain/pH dual-responsive lytic peptide-paclitaxel conjugate for synergistic cancer therapy
by: Shanshan Zheng, et al.
Published: (2022) -
Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy
by: Yongshuang Li, et al.
Published: (2020)